LARS™
Ligament Augmentation & Reconstruction System
LARS™ Ligament Augmentation & Reconstruction System offers a broad
range of synthetic ligaments for use in a wide variety of applications –
from anterior cruciate ligament (ACL) and posterior cruciate ligament
(PCL) reconstructions, to ankle and shoulder repairs.
A new era in soft tissue internal fixation:
First introduced in 1992, LARS™ ligaments are gaining popularity as an
internal fixation device providing a scaffold for natural tissue in-growth.
LARS™ has been developed to avoid the problems faced with synthetic
ligaments in the past by incorporating a patented ‘pre-twisted parallel
fibre’ concept.
• Enhanced stability1,2
• Rapid recovery1,2
• Early mobilisation1,2
• No tissue harvesting in
multi-ligament reconstruction
• No further loss of
proprioception
Using a design which mimics the native anatomic ligament fibres –
intra-articular longitudinal fibres resist fatigue and allow
fibroblastic in-growth, whilst extra-articular woven fibres
provide strength and resistance to elongation.
• Patented pre-twisted
parallel fibre concept
• Progressive
manufacturing technology
• Refined surgical
indications
LARS™ has been successfully used for more than 15 years in a wide
variety of patients – from members of the general public requiring
a fast return to daily activities through to elite athletes at the
top of their game.
LARS™ ligaments are used in countries such as the UK, France,
Germany, Canada and Australia. Regulatory approval has been granted
for LARS™ in all countries where it has been sought.
To date, over 400 surgeons have successfully implanted LARS™
worldwide in a variety of applications. This number continues
to grow as the potential of LARS™ becomes more widely recognised
and understood.
